Authors/Disclosures
|
Sarah Benisty, MD
(Hadassah Hospital, Dept of Neurology)
|
No disclosure on file |
|
|
No disclosure on file |
|
Anand Viswanathan, MD
(Massachusetts General Hospital)
|
Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Michael O'Sullivan, MD, PhD, FRACP
|
Prof. O'Sullivan has nothing to disclose. |
|
Martin Weygandt, PhD
(Charite - Universitatsmedizin Berlin)
|
No disclosure on file |
|
Marie-Germaine Bousser, MD
(Hospital Lariboisiere)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |